Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions
Lists
Only you see this
Abstract
Acute promyelocytic leukemia (APL) is a unique disease entity in acute myeloid leukemia (AML), characterized by the expansion of leukemic cell block at the promyelocytic stage. The vast majority of APL patients bear t(15;17)(q24;q21) involving the promyelocytic leukemia ( PML ) gene at chromosome
BibTeX
@inproceedings{wen2018clinical,
author = {Lijun Wen and Yang Xu and Yao Li and Nana Wang and Qinrong Wang and Tianhui Liu and Jinlan Pan and Jiannong Cen and Huifeng Zhou and Miao Miao and Yang Shao and Xiaonan Wang and Xiaoxia Wang and Changgeng Ruan and Depei Wu and Suning Chen},
title = {{Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions}},
booktitle = {Haematologica},
year = {2018},
doi = {10.3324/haematol.2018.205369},
}Loading related content...